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ABSTRACT 
Objective: To synthesize mesoporous silica nanoparticles using the sol-gel method and to determine the antibacterial activity of mesoporous silica 
nanoparticles and tetracycline loaded mesoporous silica nanoparticles. 
Methods: In the synthetic procedure, the surfactant Cetyl Trimethyl Ammonium Bromide (CTAB) is initially dissolved in basic aqueous solution, 
and the mixture is vigorously stirred. Tetra Ethyl Ortho Silicate (TEOS) is added, and the solution is kept stirring for 6 h. After the reaction is 
complete, the as-synthesized product is filtered and washed with deionized water. The antibacterial was tested using disc diffusion method and 
minimum bactericidal concentration (MBC). 
Results: The synthesized mesoporous silica nanoparticles were characterized by using Scanning Electron Microscope (SEM) micrographs showed 
spherical particles with an average size of 350 nm. The powder X-Ray Diffraction (XRD) analysis of the material further confirmed the crystallinity 
of the mesopores as evidenced by the diffraction pattern of an intense peak at θ=24º. Fourier Transf orm Infra Red Spectroscopy (FTIR) indicated 
the involvement of carboxyl, amine and hydroxyl groups in the synthetic process. The result shows the inhibitory growth zone of 20 mm and 18 mm 
for tetracycline loaded mesoporous silica nanoparticles against Escherichia coli and Staphylococcus aureus respectively. 
Conclusion: To summarize, it has been experimentally demonstrated that mesoporous silica nanoparticle and tetracycline loaded mesoporous silica 
nanoparticles show very good antimicrobial behavior against the gram-positive (Staphylococcus aureus) and gram negative (Escherichia coli) bacteria. 
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INTRODUCTION 
Nanoparticles are being viewed as fundamental building blocks of 
nanotechnology. The most important and distinct property of 
nanoparticles is that they exhibit larger surface area to volume ratio. 
The most effective studied nanoparticles today are those made from 
noble metals, in particular, Ag, Pt, Au and Pd. In past decade, 
mesoporous silica materials have received growing attention due to 
their potential biomedical application [1]. Mesoporous silica is a 
form of silica, and it is used in recent development in 
nanotechnology [2]. Mesoporous silica nanoparticles have a unique 
properties, including high surface area, a tunable pore size and 
volume, stable mesoporous structure, well-defined surface 
properties and favorable biocompatibility [3]. The most common 
types of mesoporous silica materials, such as mobile composition of 
materials (MCM)-41/48, Santa Barbara amorphous silica (SBA)-15, 
Michigan State University silica (MSU)-n, Korean Institute of 
technology silica (KIT)-1 and folded sheet-derived mesoporous silica 
(FSM)-16 [4, 2]. The recently developed sol-gel technique for the 
synthesis of mesoporous silica nanoparticles has shown great 
promise to the biomedical application by offering new possibilities 
for embedding antibiotics within silica and for controlling their 
release from the host matrix into the surrounding medium. The 
composition of silica sol-gels that can be tuned and the fabrication 
method at low temperatures enable them to carry biologically active 
agents and to be useful as a drug delivery system [5] Their synthesis 
of mesoporous silica microsphere was based on the well-established 
stober reaction for the synthesis of monodisperse non-porous silica 
spheres. It has several fascinating properties such as large surface 
area, excellent mechanical and thermal stability, low hemolytic, low 
toxicity, high biocompatibility, high drug loading capacity, and highly 
permeable porous shell for easy loading and release of guest species. 
Design and synthesis of hollow micro-nanostructures have been 
intensively pursued in the past decade. As a special type of these 
materials, hollow mesoporous silica spheres (HMSS) have attracted 
increasing attention especially in drug delivery [6]. The structure of 
the composite nanoparticles acts as the drug loading core, the co-
polymer-liposome serves as the gating shell [7]. That shell structure 
of mesoporous silica nanoparticles system has emerged as a 
promising drug system for cancer therapy [8]. The invention 
provides an antimicrobial delivery system that allows for delayed 
release of antibacterial agents from a single application of 
mesoporous silicate particle antibacterial delivery system include 
one or more amines group covalently bonded to the pores or the 
surface of the mesoporous silicate particles, wherein the amino acid 
influences the release rate of an antimicrobial agent [9]. The use of 
nanoparticles containing antibiotics has demonstrated numerous 
advantages. Nanoparticles are used in wide range of applications as 
an antibacterial agent in disinfecting devices, cosmetics, home 
appliances, electronics, catalysis, chemistry, energy, medicine and 
water treatment plants [19,21].  
As the antibiotic is held into the nanoparticles, chemical composition 
and modifications on the nanoparticles surface enable to prolong, 
localize, target and have a protected drug interaction with the 
diseased tissue. In this way, higher antibiotic concentrations are 
attained in the targeted cells, managing to reduce the frequency of 
the dosages taken, reducing the drug side effects and fluctuation in 
circulating levels, thus improving the overall pharmacokinetics. 
Other benefits of this type of drug delivery systems applied to 
antibiotic therapy are the reduction of the antimicrobial resistance, 
the enhancement of the solubility of some antibiotics and the 
widener therapeutic index [10]. Recent advances in the field of 
nanotechnology have made it possible to detect microorganisms 
using nanoparticles functionalized with oligonucleotides 
complementary to the gene tags of microorganisms [20]. In the 
present investigation, we report the synthesis of mesoporous silica 
nanoparticles followed by its drug loading efficiency. Further is 
efficacy to inhibit gram-negative bacteria (Escherichia coli) and 
gram-positive (Staphylococcus aureus) were evaluated [11]. 
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MATERIALS AND METHODS 
Chemicals 
Cetyl Trimethyl Ammonium Bromide and Tetra Ethyl Ortho Silicate 
was procured from Sigma Aldrich.  
Synthesis of mesoporous silica nanoparticles 
Mesoporous silica particles with organo-functionalized groups 
covalently bonded to the pores can be prepared by the procedure 
described below. N-Cetyl Trimethyl Ammonium Bromide (CTAB) 1 g 
was dissolved in 480 ml of deionized water. Sodium hydroxide 
(NaOH) 2 mol was added to CTAB solution, followed by adjusting the 
solution temperature to 80 °C. TEOS 5 ml was introduced dropwise 
to the surfactant solution. The mixture was allowed to stir for 6 h to 
give white precipitates (as synthesized thiol-Sphere). The solid 
product was filtered, washed with ethanol and deionized water and 
dried in air. To remove the surfactant template (CTAB), 1.5 g of as-
synthesized thiol-Sphere was refluxed for 24 h in a solution of 9 ml 
of hydrochloric acid and washed with deionized water. The resulting 
surfactant-remove thiol mesoporous sillica material was placed 
under high vacuum to remove the remaining solvent in the 
mesopores.  
Drug loading method 
Mesoporous silica nanoparticle (10 mg/ml) was dispersed into 
tetracycline aqueous solution (1 mg/ml). Tetracycline-loaded 
mesoporous silica nanoparticles were obtained by centrifugation; 
then the products were washed with deionized water twice to 
removed the tetracycline absorbed on the surface. The supernatant 
and the washing liquor were collected, and the residual tetracycline 
was evaluated by using the calibration curves of standard 
tetracycline solutions obtained by UV-Vis spectroscopy. 
The drug loading efficiency was calculated from the following 
equation:  
loading efficiency(wt %) =
 mass of drug in the MSNs
 Mass of the drug–loaded MSNs 
 
Scanning electron microscopy analysis 
SEM was used to analyze the shape and size for the synthesized 
Mesoporous silica nanoparticle. The pellet was mixed properly and 
carefully placed on a glass coverslip followed by air-drying. The 
coverslip itself was used during scanning electron microscopy (SEM) 
analysis. The images of mesoporous silica nanoparticles were 
obtained in a scanning electron microscope (VGEA3 TESCAN).  
X-ray diffraction (XRD) analysis 
Synthesized mesoporous silica nanoparticles were subjected to XRD 
analysis. The XRD (REGAKU mini flex 600) studies were performed 
with, Cu Kα radiation (λ = 1.54 nm) in the 2θ range of 30–80 operate 
data voltage of 40 kV and a current of 30 mA. 
Fourier transforms infrared spectroscopy (FTIR)  
FTIR analysis of the mesoporous silica nanoparticles was carried out 
through the potassium bromide (KBr) pellet (FTIR grade) method in 
1:100 ratio and spectrum was recorded using Jasco FT/IR-6300 
Fourier transform infrared spectrometer equipped with JASCO IRT–
7000 Infrared microscopes using transmittance mode operating at a 
resolution of 4 cm-1. 
Antimicrobial activity studies 
The disc diffusion method was used to screen the antibacterial 
activity of the synthesized mesoporous silica nanoparticles against 
gram-positive (Staphylococcus aureus) bacteria and gram negative 
(Escherichia coli) bacteria as test microorganisms. In vitro 
antibacterial activity was screened by using muller hinton agar 
(MHA) obtained from Himedia. The Muller hinton agar plates were 
prepared by pouring 15 ml of media into the sterile Petri dish plates. 
The plates were allowed to solidify for 5 min and 0.1% inoculum 
suspension was swabbed uniformly, and the inoculum was allowed 
to dry for 5 min. 50 µl concentration of test sample (mesoporous 
silica nanoparticles) was loaded on 0.5 cm sterile disc. The loaded 
disc was placed on the surface of the medium and the compound 
was allowed to diffuse for 5 min and the plates were kept for 
incubation at 37 °C for 24 h. At the end of incubation, inhibition 
zones formed around the disc were measured with a transparent 
ruler in millimeter.  
MIC and MBC determination of tetracycline-loaded mesoporous 
silica nanoparticles 
The minimum inhibitory concentration (MIC) was determined using 
micro broth dilution methods. The concentration of synthesized 
nanoparticles (1 to 5) dilution was prepared using tubes containing 
750 µl of broth the tubes were inoculated with the suspension of 
standardized inocula were added and incubated at 37 °C for 24 h. 
minimum inhibitory concentrations were recorded as the lowest 
concentration of synthesized nanoparticles showing no visible 
growth in the broth. The minimum bactericidal concentration was 
determined by CFU method. From the corresponding MIC tubes (10-
1, 10-2,10-3, 10-4, 10-5) take 0.5 ml of culture and gently speared on 
the muller hinton agar plates that plates incubated at 37 °C for 
overnight after the incubation colony forming units were counted, 






RESULTS AND DISCUSSION 
Synthesis of mesoporous silica nanoparticles  
Synthesis of mesoporous silica nanoparticles using sol-gel method 
was confirmed by the formation of white color precipitation after 
adding TEOS (Tetra Ethylene Ortho Silica) to CTAB solution while 
continuous stirring. The synthesis of MSNs is performed at a low 
surfactant concentration to make the assembly of the ordered 
mesophases strongly depends on upon the interaction between 
the cationic surfactant and the growing anionic oligomer 
orthosilicic acid, which in turn limits the assembly of mesophases 
to small sizes [12]. The first material reported by the mobile 
researchers (MCM-41) was micrometer-sized particles with 
spherically ordered mesopores [13]. 
Scanning electron microscopy analysis of mesoporous silica 
nanoparticles 
A silica nanoparticle represents a new class of mesoporous silica 
nanomaterials with a hollow spherical and mesoporous structure. 
SEM image of mesoporous silica nanoparticles are shown in fig. 1. 
The mesoporous silica nanoparticles with a mean diameter of about 
350 nm were synthesized using a Tetra Ethyl Ortho Silicate (TEOS) 
as the silica precursors and Cetyl Trimethyl Ammonium Bromide 
(CTAB) as the pore forming agent. When simply treated by Na2CO3 in 
the presence of CTAB in an appropriate concentration, as the solid 
Stober spheres were successfully converted into uniform hollow 
spheres [6, 14]. 
 
 
Fig. 1: SEM analysis of the synthesized mesoporous silica 
nanoparticles 
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The elemental analysis of the mesoporous silica nanoparticles was 
performed using the Energy Dispersive Spectrum on the SEM. Fig. 2 
shows the EDS spectrum of the spherical nanoparticles prepared 
with CTAB as pore forming agent. The peaks around 0.5 kV and 1.9 
kV are corresponding to the binding energies of O and Si, 
respectively. Silica has the weight percentage as 23.59 %. The rest of 
the lines of the EDS spectrum correspond to the other elements (Na, 
Br and Cl). 
 
 
Fig. 2: EDS anylsis of synthesized mesoporous silica 
nanoparticles 
 
X-ray diffraction (XRD) analysis of mesoporous silica 
nanopaticles 
The X-ray diffraction pattern is used to determine the crystalline 
structure of the silica nanoparticles. Investigation of the XRD 
provides evidence of the presence of silica nanoparticles. The fig. 3 
shows that the particles are crystalline in nature.  
 
 
Fig. 3: Powder XRD–pattern of synthesized mesoporous silica 
nanoparticles 
The intense peak at θ=24⁰ indicates the silica peak which represents 
the crystalline nature due to the smaller particle size effect and 
incomplete inner structure of the nanoparticles. XRD pattern 
observed for mesoporous silica nanoparticles a number of bragg’s 
reflections corresponding to the (111), (200), (220) sets of lattice 
planes are observed that may be indexed on the basic of fcc 
structure of mesoporous silica nanoparticles [8, 15]. 
Fourier transforms infrared spectroscopy (FTIR) analysis of 
mesoporous silica nanoparticles  
The Fourier transform infrared (FTIR) spectra of synthesized 
mesoporous silica nanoparticles were recorded using a JASCO IR–
7000 at room temperature using KBr pellets. Fig. 4 shows the FTIR 
spectra of,mesoporous silica nanoparticles, Tetracycline loaded 
mesoporous silica nanoparticles and Tetracycline. It can be seen that 
there is a very pronounced band appearing at 1066 cm-1, together 
with less pronounced bands at 795 cm-1 in the spectrum of MSN, 
corresponding to the vibration absorption of Si–O–Si groups. 
Tetracycline is confirmed by new bands at around 3376 cm-1, 3302 
cm-1, 1457 cm-1, 1123 cm-1, 949 cm-1and 1356 cm-1a typical 
absorption peak of alcohols, phenols, amines, aromatic ring, 
carboxylic acids, esters, and alkanes respectively.  
The Tetracycline loaded MSN spectrum is characterized by 
broadband around 3405 cm-1 corresponding to NH stretching 
vibration, two narrow bands at 2922 and 2852 cm-1 attributed to 
CH2 stretching vibrations, bands between 1750 and 1500 cm-1 
corresponding to amide vibrations and a narrow peak at 1479 cm-1 
indicating the presence of CO2-carboxylate groups. The peak 
intensity was high at 1636 cm-1 a typical absorption peak of NH bend 
(primary amines) and C–F vibration respectively. The presence of 
these broad peaks also confirms successful loading of drug into the 
nanoparticles. Where oxygen atom plays the role of a bridge 
between two silicon sites. Showing absorption bands at 1678 and 
1627 cm-1 for the tetracycline have the aromatic ring [12, 16]. 
Study of antibacterial activity of mesoporous silica 
nanoparticles 
Nanoparticles showed effective antibacterial activity both in gram 
negative and gram positive compared the Antibacterial activity of 
synthesized mesoporous silica nanoparticles against gram negative 
(Escherichia coli) and gram-positive (Staphylococcus aureus) 
bacteria reveals an antibacterial activity. The result indicated that, 
the mesoporous silica with the positive control (tetracycline) and 
negative control (DMSO). Form the result it was confirmed that, the 
effect of mesoporous silica nanoparticles is responsible for the 
effective antibacterial activity when compared with the positive 
control (tetracycline) and negative control (DMSO). The result 
shows (fig. 5) inhibition zone of mesoporous silica nanoparticles, 
positive control (Tetracycline) and no zone formation of negative 
control (DMSO) is presented. 
 
 
Fig. 4(a): FTIR spectra of Mesoporous silica nanoparticles 
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Fig. 4(b): FTIR spectra of tetracycline 
 
 
Fig. 4(c): FTIR spectra of tetracycline-loaded mesoporous silica nanoparticles 
 
 
Fig. 5: Comparison between the positive control (Tetracycline), 
negative control (DMSO) and mesoporous silica nanopaticles 
against (a) Escherichia coli, (b) Staphylococcus aureus 
 
The highest tetracycline loading efficiency (57 %) could be ascribed 
to the hollow cavity in the center of mesoporous silica nanoparticles. 
The invention provides an antimicrobial delivery system that allows 
for delayed release of antibacterial agents from a single application 
of mesoporous silicate particles antibacterial delivery system 
include one or more amines group covalently bonded to the pores or 
the surface of the mesoporous silicate particles, wherein the amino 
acid influences the release rate of an antimicrobial agent [8, 17]. 
Antibacterial activity of synthesized mesoporous silica nanoparticles 
against gram negative (Escherichia coli) and gram-positive 
(Staphylococcus aureus) bacteria reveals an antibacterial activity. 
The result indicated that tetracycline is loaded mesoporous silica 
nanoparticles showed effective antibacterial activity both in gram 
negative and gram positive compared with the drug (Tetracycline). 
From the result it was confirmed that the combined effect of 
mesoporous silica nanoparticles and tetracycline is responsible for 
the effective antibacterial activity when compared with the drug 
(Tetracycline) alone.  
 
 
Fig. 6: Comparison between the mesoporous silica 
nanoparticles, drug (Tetracycline) and Tetracycline loaded 
mesoporous silica nanoparticles. (a) Escherichia coli, (b) 
Staphylococcus aureus 
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The result and images inhibition zone of mesoporous silica 
nanoparticles, tetracycline and tetracycline loaded mesoporous silica 
nanoparticles (fig. 6). The inhibition zone was found to be 10 mm for 
mesoporous silica nanoparticles, 15 mm for tetracycline and 20 mm 
for tetracycline mesoporous silica nanoparticles against Escherichia 
coli. The inhibition zone was found to be 5 mm for mesoporous silica 
nanoparticles, 10 mm for tetracycline and 18 mm for tetracycline 
mesoporous silica nanoparticles against Staphylococcus aureus. 
Effect of concentration of tetracycline-loaded mesoporous silica 
nanoparticles on gram negative and gram positive bacteria 
The result of the antibacterial activity of various concentrations of 
tetracycline-loaded mesoporous silica nanoparticles is shown in 
(table 1 and fig. 7). The most potent effect, related to tetracycline 
loaded mesoporous silica nanoparticles showed inhibition effect, 
against gram-negative bacteria (Escherichia coli) as well as gram 
positive bacteria (Staphylococcus aureus) in a similar degree of 
inhibition zone.  
The inhibition zone was found to be 10, 12, 15 and 20 for 50, 100, 
150, and 200 mg/ml concentration of mesoporous silica 
nanoparticles against gram-negative bacteria and the inhibition 
zone was found to be 8, 10, 13, and 15 mm for 50, 100, 150 and 200 
mg/ml concentration against gram-positive bacteria. The result 
shows that the growth of the bacteria decreased with the increase in 
the concentration of tetracycline-loaded mesoporous silica 
nanoparticles. 
 
Table 1: Antibacterial activity of tetracycline-loaded mesoporous silica nanoparticles 
S. No. Test organisms Drug Drug (Tetracycline) loaded  mesoporous silica nanoparticles 
50 mg/ml  50 mg/ml  100 mg/ml  150 mg/ml  200 mg/ml 
Zone of inhibition (mm) (mean±SD)  
 1. Escherichia coli 11.5±0.4 9.6±0.57 12.16±0.2 14.23±0.7 18.9±0.5  
 2. Staphylococcus aureus 8.7±0.2 7.4±0.37 9.7±0.2 12.6±0.4 14.9±0.2  
Each value represents the mean±SD of three replicates per treatment in three repeated experiments. 
 
 
Fig. 7: Antibacterial activity of tetracycline-loaded mesoporous 
silica nanoparticles in different concentration. (a) Escherichia 
coli, (b) Staphylococcus aureus 
 
Minimum bactericidal concentration (MBC) of tetracycline-
loaded mesoporous silica nanoparticles 
To determine the lowest concentration of tetracycline-loaded 
mesoporous silica nanoparticles that completely inhibit the visible 
growth of bacteria minimum bactericidal concentration was performed.  
 
Fig. 8(a): MBC determination of tetracycline-loaded 
mesoporous silica nanoparticles against Escherichia coli 
The MBC of tetracycline-loaded mesoporous silica nanoparticles 
against Escherichia coli and Staphylococcus aureus are shown in fig. 
8. Minimum bactericidal concentration was measured by CFU/ml 
and the cell reduction was found to be 100%, 97 %, 90 %,72 % and 
50 % for 10-1, 10-2, 10-3, 10-4and 10-5respectively for Escherichia coli 
and 100%,96%, 89%, 66%, 54% for 10-1, 10-2, 10-3, 10-4and 10-
5respectively for Staphylococcus aureus. The result shows the 
antibacterial activity of tetracycline-loaded mesoporous silica 
nanoparticles against gram negative (Escherichia coli) was higher 
than compared to gram-positive (Staphylococcus aureus). 
 
 
Fig. 8(b): MBC determination of tetracycline-loaded 
mesoporous silica nanoparticles against Staphylococcus aureus 
 
The hollow mesoporous silica spheres have large surface area, high 
pore volume, and controllable structure parameters. The cationic 
surfactant plays critical roles in forming the hollow mesoporous 
structure. A formation mechanism involving the etching of solid SiO2 
accelerated by cationic surfactant followed by the redeposition of 
dissolved silica species directed by cationic surfactant is proposed 
[6, 18]. A recent report has demonstrated the antibacterial activity 
of mesoporous silica nanoparticles on both Gram positive and Gram 
negative microbes. The mechanism of the antibacterial activity of 
Sujitha et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 5, 196-201 
 
201 
mesoporous silica nanoparticles was attributed to the electrostatic 
interaction of phosphate groups on the microbial cell wall and the 
cationic head group of the mesoporous silica nanoparticles. Also, the 
organic tail region embeds itself in the lipid bilayer. This, in turn, 
leads to the free flow of electrolytes out of the microbe and causes the 
cell death. This is believed to be the mechanism of cell death [8, 19]. 
CONCLUSION 
To summarize, in this study, we have successfully synthesized the 
mesoporous silica nanoparticles using the sol-gel method. The use of 
cationic surfactant, Cetyl Trimethyl Ammonium Bromide (CTAB) is 
critical to the formation of hollow mesoporous structure. 
Antibacterial activity of mesoporous silica nanoparticles and 
tetracycline loaded mesoporous silica nanoparticles was carried out 
using tetracycline as a positive control for gram-positive 
(Staphylococcus aureus) and gram negative (Escherichia coli) 
bacteria. The antibacterial studies suggest that the mesoporous 
silica nanoparticles can be used as potential drug candidature to 
treat various diseases. 
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